MLchartDataset catalogue

PAD

Term · Oncology and biomedicine · MLC-T-ONC-006249

An abbreviation for a chemotherapy combination used to treat multiple myeloma. It includes the drugs bortezomib, doxorubicin (Adriamycin), and dexamethasone. Also called PAD regimen.

Table 1. Record
IdentifierMLC-T-ONC-006249
FieldOncology and biomedicine
ExpansionsPAD regimen
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-006249",
  "term": "PAD",
  "field": "Oncology and biomedicine",
  "definition": "An abbreviation for a chemotherapy combination used to treat multiple myeloma. It includes the drugs bortezomib, doxorubicin (Adriamycin), and dexamethasone. Also called PAD regimen.",
  "expansions": [
    "PAD regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/pad/"
}

Record 12,506 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.